Home Sienna Biopharmaceuticals

Sienna Biopharmaceuticals

In operation
IPO Delisting
Developer of New Drugs in Medical Dermatology and Aesthetics
Basic
Enterprise Profile

Basic Information

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of first-in-class, targeted topical products for medical dermatology and aesthetics by applying innovations in biotechnology. Sienna aims to develop an innovative, diversified, multi-asset pipeline of topical therapies to improve the health, appearance, and quality of life for dermatology and aesthetics patients. Sienna’s management team has extensive experience in product development and commercialization at several leading dermatology, aesthetics, and biotechnology companies.
Sienna Biopharmaceuticals, Inc.
California,United States of America
15~50 people
January 01, 2010
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Biotechnology
Concept
Dermatology Department Therapeutic Products
Application Scenarios
Medical Aesthetics Innovative Drugs